Furthermore, epitope spreading as evaluated here for CD8+ T cells may likewise occur for CD4+ T cells, and further insight into the relationship between CD4+ and CD8+ tumor-reactive T cells and the relevance for shared antigen recognition are critical aspects for addressing future improvements in immunotherapy. The gene discussed is CD8A; the disease is neoplasm.